ArticleNeuro-oncology2026

Single-nucleus transcriptomics, pharmacokinetics, and pharmacodynamics of CDK4/6 and mTOR inhibition in a Phase 0/1 trial of recurrent high-grade glioma.

Kevin C Johnson et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.